Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone dipropionate/formoterol pMDI vs budesonide/formoterol in COPD (China)
CTR20180475Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started May 2018; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20180475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180475.